The Sucralfate 4% Gastric Tube Liquid is a specially compounded medication intended for administration through a gastric tube. This formulation is designed to provide a safe and accurate dosing alternative for patients who are unable to take oral medications, including those in hospital settings or individuals with swallowing difficulties. The liquid consistency of the medication ensures compatibility with gastric tubes, facilitating ease of use for caregivers and healthcare professionals.
Sucralfate is primarily used in the treatment and management of active duodenal ulcers. It also serves as a protective agent for the stomach lining, making it beneficial in the prevention of gastric ulcers in patients who are at increased risk. Additionally, this formulation can be used to treat and prevent ulcers in the mouth and throat in patients receiving radiation therapy for head and neck cancer, as well as to manage gastritis and gastroesophageal reflux disease (GERD) when alternative treatments are not suitable or available.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Sucralfate 4% Gastric Tube Liquid is a specially compounded medication designed for ease of administration through a gastric tube. This formulation is particularly beneficial in hospital settings or for individuals with swallowing difficulties, ensuring that they receive the necessary medication in a safe and controlled manner. Sucralfate, the active ingredient, is a cytoprotective agent that works primarily in the lining of the stomach by adhering to ulcer sites and protecting them from acids, enzymes, and bile salts. This creates a physical barrier that promotes healing and prevents further damage.
The liquid formulation of sucralfate is ideal for patients with enteral feeding tubes as it ensures the medication can be delivered directly to the gastrointestinal tract without the need for swallowing. This is crucial for maintaining the treatment regimen in patients with esophageal or gastric disorders, who may otherwise be unable to receive their medication. Sucralfate 4% Gastric Tube Liquid is commonly used to treat a variety of gastrointestinal diseases, including peptic ulcer disease, gastroesophageal reflux disease (GERD), and stress ulcers. It may also be used in the management of mucositis caused by radiation or chemotherapy, and in the prevention of oral and esophageal ulcers.
For prescribers, it is important to note that sucralfate should be used with caution in patients with renal impairment due to the risk of aluminum accumulation. Additionally, sucralfate may interact with other medications by binding to them in the stomach and reducing their absorption. Therefore, a thorough medication review is recommended to avoid potential drug interactions. The 4% concentration allows for precise dosing, which can be adjusted based on the patient's specific needs and the severity of their condition.
Patients and caregivers should be instructed on the proper administration techniques when using a gastric tube, including flushing the tube before and after medication delivery to maintain patency and ensure complete dosing. It is also important to maintain proper storage conditions for the medication and to be aware of its shelf life to ensure its efficacy.
If you have any questions or require further information about the Sucralfate 4% Gastric Tube Liquid formulation, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is dedicated to providing comprehensive support and guidance to both patients and healthcare providers to ensure optimal treatment outcomes.
Sucralfate is a medication primarily used to treat and prevent ulcers in the stomach and intestines. It works by creating a protective barrier on the ulcer site against stomach acid and enzymes, allowing healing to occur. While sucralfate is generally safe, it can interact with a variety of medications, potentially altering their effects. It is important for both patients and prescribers to be aware of these interactions to ensure the efficacy and safety of all concurrent medications.
One of the most significant interactions occurs with antacids. While antacids can be used to relieve the discomfort associated with ulcers, they should not be taken within 30 minutes before or after sucralfate administration. This is because antacids can interfere with the action of sucralfate, reducing its effectiveness. Similarly, sucralfate can affect the absorption of a wide range of drugs by binding to them in the stomach and preventing their proper absorption into the bloodstream. This is particularly true for drugs that require an acidic environment for absorption or those that can bind to sucralfate.
Medications that may have reduced absorption when taken with sucralfate include, but are not limited to, fluoroquinolone antibiotics (such as ciprofloxacin and levofloxacin), tetracycline antibiotics, levothyroxine, phenytoin, digoxin, warfarin, and certain antifungal agents like ketoconazole. To minimize this interaction, these medications should be administered at least 2 hours before or after sucralfate. This allows sufficient time for the medication to be absorbed before sucralfate is introduced into the system.
For patients with renal impairment, caution is advised when using sucralfate, as it contains aluminum. In patients with normal renal function, aluminum is eliminated in the urine, but in those with renal impairment, aluminum accumulation can occur, potentially leading to toxicity. Therefore, monitoring of aluminum levels in patients with compromised renal function is recommended when sucralfate is used for a prolonged period.
It is also important to note that sucralfate may alter the rate and extent of absorption of some drugs due to its effects on gastric emptying and pH. Prescribers should closely monitor patients for changes in drug efficacy or side effects when initiating or discontinuing sucralfate therapy. Additionally, sucralfate should be used with caution in diabetic patients as it may contain carbohydrates that can affect blood glucose levels.
Lastly, dietary considerations should be taken into account. Sucralfate should be administered on an empty stomach, preferably one hour before meals, to ensure optimal absorption and effectiveness. However, specific patient needs may vary, and feeding schedules for patients with gastric tubes should be adjusted accordingly in consultation with a healthcare professional.
Prescribers and patients should work closely with their healthcare team, including pharmacists, to manage these interactions. If you have any questions or concerns regarding sucralfate therapy and potential drug interactions, please reach out to us at Bayview Pharmacy for personalized advice and support.
Sucralfate 4% Gastric Tube Liquid is a specially crafted medication that is administered through a gastric tube directly into the stomach. This formulation is designed for patients who are unable to take oral medications due to various reasons such as swallowing difficulties, unconsciousness, or the presence of esophageal disorders. The liquid form ensures that the medication can be easily and safely delivered through the tube, providing a practical solution for those in hospital settings or with long-term care needs.
The active ingredient in this formulation, sucralfate, works primarily by adhering to the mucosal lining of the gastrointestinal tract. It acts locally, not systemically, which means it does not get absorbed into the bloodstream. Instead, sucralfate forms a protective barrier over ulcerated areas, effectively shielding them from the corrosive effects of stomach acid and pepsin. This barrier promotes healing and provides relief from pain and discomfort associated with active ulcers.
Sucralfate is particularly useful in treating diseases such as peptic ulcer disease, gastritis, and gastroesophageal reflux disease (GERD). In the case of peptic ulcers, sucralfate binds to the ulcer site and can remain adhered there for up to six hours, providing prolonged protection. It also stimulates mucosal defenses by increasing bicarbonate and mucus production, which further helps to buffer gastric acid and promote healing. Additionally, sucralfate has been shown to inhibit the activity of pepsin—an enzyme that contributes to ulcer formation—when the pH of the stomach is less than 4.
For patients and prescribers considering the use of Sucralfate 4% Gastric Tube Liquid, it is important to note that the timing of administration is crucial for maximizing its therapeutic effects. It is typically administered on an empty stomach, about one hour before meals and at bedtime, to ensure that it can effectively coat the ulcer sites without interference from food or other medications. It is also essential to shake the bottle well before use to ensure that the medication is evenly distributed in the liquid suspension.
As with any medication, there may be potential interactions with other drugs, so it is important to inform the healthcare provider of all medications the patient is currently taking. If you have any questions about this formulation or its administration, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is dedicated to providing the highest quality of care and is ready to assist with any inquiries or concerns you may have.
Sucralfate 4% Gastric Tube Liquid is used to treat and prevent ulcers in the digestive tract by forming a protective barrier on the ulcer surface. It is especially beneficial for patients who are unable to take oral medication and need treatment administered through a gastric tube.
This medication is specifically formulated for administration via a gastric tube. The liquid is delivered directly into the stomach through the tube, ensuring precise dosing and accommodating patients who have swallowing difficulties or are unable to receive oral medication.
It's important to consult with a healthcare professional before combining Sucralfate with other medications. Sucralfate can interact with some drugs by affecting their absorption, so it may be necessary to adjust dosing times.
Common side effects may include constipation, dry mouth, and upset stomach. It is generally well-tolerated, but if you notice more serious side effects or if common side effects persist or worsen, consult a healthcare provider.
If you miss a dose, administer it as soon as possible. If it is near the time of the next dose, skip the missed dose and resume your usual dosing schedule. Do not double the dose to catch up.
Store the medication at room temperature, away from direct light and moisture. Do not freeze it. Keep the medication out of the reach of children and pets.
Sucralfate 4% Gastric Tube Liquid may be used in children if prescribed by a healthcare provider. Dosage and administration should be closely monitored by a professional.
Avoid taking any oral medications within 30 minutes before or after taking Sucralfate, as the absorption of other medicines can be affected. Additionally, avoid smoking and consuming alcohol as these can exacerbate digestive issues.
The duration of treatment with Sucralfate 4% Gastric Tube Liquid varies based on the individual patient's condition and response to therapy. Follow the healthcare provider's instructions regarding the duration of its use.
A balanced diet that avoids irritants, such as spicy foods, acidic beverages, and caffeine, can improve gastrointestinal health. Consult with a healthcare provider for dietary recommendations tailored to your specific condition.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.